Hongxia Wang

Hongxia Wang

Vertex Pharmaceuticals - Boston / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4614000
-
person_outline Hongxia Wang's MOST POPULAR ARTICLES
1-) Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacyHJ Li, JZ Du, XJ Du, CF Xu, CY Sun, HX Wang, ZT Cao, XZ Yang, YH Zhu, ...Proceedings of the National Academy of Sciences 113 (15), 4164-4169, 20165802016
2-) Single‐Layered Graphitic‐C3N4 Quantum Dots for Two‐Photon Fluorescence Imaging of Cellular NucleusX Zhang, H Wang, H Wang, Q Zhang, J Xie, Y Tian, J Wang, Y XieAdvanced materials 26 (26), 4438-4443, 20144932014
3-) CRISPR/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral deliveryHX Wang, M Li, CM Lee, S Chakraborty, HW Kim, G Bao, KW LeongChemical reviews 117 (15), 9874-9906, 20173752017
4-) Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptideHX Wang, Z Song, YH Lao, X Xu, J Gong, D Cheng, S Chakraborty, ...Proceedings of the National Academy of Sciences 115 (19), 4903-4908, 20182782018
5-) Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapyXZ Yang, S Dou, TM Sun, CQ Mao, HX Wang, J WangJournal of controlled release 156 (2), 203-211, 20112612011